Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Epilepsy Res. 2016 Jan 29;121:21–28. doi: 10.1016/j.eplepsyres.2016.01.009

Table 3.

Seizure outcomes and associated factors

MEG slowing No MEG slowing p value
A) Patient demographics
Age years 20.0 ± 3.3 28.2 ± 1.4 < 0.01*
Gender Male 14 (19.2) 59 (80.8) 0.34
Female 7 (11.9) 52 (88.1)
Handedness Right 13 (13.4) 84 (86.6) 0.06
Left 2 (11.1) 16 (88.9)
Ambidextrous/unknown 6 (35.3) 11 (64.7)
B) Epilepsy characteristics
Duration epilepsy years 8.0 ± 1.5 15.2 ± 1.1 < 0.01*
Seizure frequency no. per week 13.1 ± 3.8 10.7 ± 2.2 0.65
AEDs tried no. 5.7 ± 0.5 4.7 ± 0.3 0.13
Lobe involved Temporal 7 (9.3) 68 (90.7) 0.03*
Extratemporal/multilobe 14 (24.6) 43 (75.4)
Primary Pathology Gliosis only 5 (11.9) 37 (88.1) 0.12
MCD 10 (30.3) 23 (69.7)
MTS 4 (16.0) 21 (84.0)
Tumor 1 (4.5) 21 (95.5)
Ischemia/infarct 1 (20.0) 4 (80.0)
Other 0 (0.0) 5 (100.0)
History of generalized seizures Yes 13 (16.7) 65 (83.3) 0.81
No 8 (14.8) 46 (85.2)
Side of surgery Right 9 (26.4) 46 (83.6) 0.99
Left 12 (15.6) 65 (84.4)
Previous resection No 18 (16.1) 94 (83.9) 0.99
Yes 3 (15.0) 17 (85.0)
C) Pre-operative diagnostics
MEG spike activity Specific to EZ 12 (17.6) 56 (82.4) 0.85
Non-specific or discordant 5 (14.3) 30 (85.7)
No spikes modelled 4 (13.8) 25 (86.2)
MRI Abnormal 18 (16.5) 91 (83.5) 0.48
Normal 3 (13.0) 20 (87.0)
Ictal scalp EEG Localized 13 (16.5) 66 (83.5) 0.99
Not localized 8 (16.0) 42 (84.0)
PET (when performed) Abnormal 4 (15.4) 22 (84.6) 0.99
Normal 2 (15.4) 11 (84.6)
TOTAL 21 (15.9) 111 (84.1)

Data are N (%) for categorical variables or mean ± SEM for continuous variables.

*

Statistically significant value (p < 0.05) from χ2 test (categorical) or t-test (continuous) comparing patients with or without asymmetric slowing on MEG.

AED: anti-epileptic drug; EEG: electroencephalography; EZ: epileptogenic zone; MCD: malformation of cortical development; MEG: magnetoencephalography; MRI: magnetic resonance imaging; MTS: mesial temporal sclerosis; PET: positron emission tomography.